A Rare Ground-Floor Entry in Hard-Rock Lithium: Elektros Inc. (OTC:ELEK) Positioned at a Bottom-Basement Valuation for Investors Seeking Early-Stage Upside
accessnewswire.com
Want to monitor COLL?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor COLLcollegium pharmaceutical, inc. is a specialty pharmaceutical company developing and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. with a substantial number of patients suffering from chronic pain, collegium is committed to developing and commercializing a portfolio of products that address the growing problems associated with non-medical use, abuse and misuse of prescription products by leveraging the company’s proprietary deterx® technology platform.